共 318 条
[1]
Kirchhof P(2016)2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS Eur J Cardiothorac Surg 50 e1-e88
[2]
Benussi S(2016)Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report Chest 149 315-352
[3]
Kotecha D(1991)Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 983-988
[4]
Kearon C(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 955-962
[5]
Akl EA(2006)Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119-125
[6]
Ornelas J(2013)Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 Eur Heart J 34 2746-2751
[7]
Wolf PA(2018)Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants Br J Anaesth 120 645-656
[8]
Abbott RD(2020)Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation Pharmacotherapy 40 40-54
[9]
Kannel WB(2020)Trends in anticoagulant prescribing: a review of local policies in English primary care BMC Health Serv Res 20 279-1963
[10]
Ruff CT(2017)Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management World J Gastroenterol 23 1954-12